Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal versus subcutaneous continuous insulin infusion PK/PD crossover study in type 1 diabetes
2009-016164-36Phase 2Completed
- Sponsor
- BD
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by BD. Primary endpoints: Pharmacokinetic response to changes in rapid-acting insulin infusion rate and Pharmacokinetic profile during initiation, stepped rate changes, and discontinuation. Started Nov 2009; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-016164-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016164-36.